Nicotine Dependence — Smokers' Response to Nicotine Dependence Genotyping
Citation(s)
Abrams, D B., Niaura, R., Brown, R.A., Emmons, K.M., Goldstein, M.G., & Monti, P.M. (2003). The Tobacco Dependence Treatment Handbook: A Guide to Best Practices. New York: The Guilford Press.
Benowitz NL Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008 Apr;83(4):531-41. doi: 10.1038/clpt.2008.3. Epub 2008 Feb 27. Review.
Brock, A J., Takeda, A., Brennan, C., & Walton, R. T. (2011). Treatment for tobacco dependence: A potential application for stratified medicine. Biomarkers Medicine, 8 (5), 571-579
Brownlee, S , Leventhal, H., & Leventhal, E. A. (2000). Regulation, self-regulation, and construction of the self in maintenance of physical health. In M. Boekaerts, P.R. Pintrich, & M. Zeidner, (Eds.). Handbook of Self-Regulation. San Diego, CA: Academic Press, pp. 369-416.
Cameron LD, Marteau TM, Brown PM, Klein WM, Sherman KA Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence. J Behav Med. 2012 Jun;35(3):286-98. doi: 10.1007/s10865-011-9361-5. Epub 2011 Jun 23.
Cappella, J N., Lerman, C., Romantan, A., & Baruh, L. (2003). News about genetics and smoking. Communications Research, 32, 478-502.
CDC (2011a) Vital signs: Current cigarette smoking among adults aged > 18 years - United States, 2005-2010. MMWR, 60 (35), 1207-1211. 2. CDC (2011b). Quitting smoking among adults - United States, 2001-2010. MMWR, 60 (44), 1513-1519.
Cervone D The architecture of personality. Psychol Rev. 2004 Jan;111(1):183-204.
Cohen, J (1988). Statistical Power Analysis for the Behavioral Sciences. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
Cokkinides VE, Ward E, Jemal A, Thun MJ Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005 Jan;28(1):119-22.
Condit CM Public understandings of genetics and health. Clin Genet. 2010 Jan;77(1):1-9. doi: 10.1111/j.1399-0004.2009.01316.x. Review.
Doak LG, Doak CC, Meade CD Strategies to improve cancer education materials. Oncol Nurs Forum. 1996 Sep;23(8):1305-12. Review.
Fiore, M C., Jaen, C.R., Baker, T.B., et al. (2008). Treating Tobacco Use and Dependence. 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
Henderson BJ, Maguire BT Three lay mental models of disease inheritance. Soc Sci Med. 2000 Jan;50(2):293-301.
Hendricks PS, Delucchi KL, Hall SM Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence. Drug Alcohol Depend. 2010 Jun 1;109(1-3):114-9. doi: 10.1016/j.drugalcdep.2009.12.021. Epub 2010 Jan 21.
Hung WT, Dunlop SM, Perez D, Cotter T Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health. 2011 Jul 27;11:592. doi: 10.1186/1471-2458-11-592.
Perkins, K A., Conklin, C.A., & Levine, M.D. (2008). Cognitive-Behavioral Therapy for Smoking Cessation. New York: Routledge.
Pleasant A, McKinney J Coming to consensus on health literacy measurement: an online discussion and consensus-gauging process. Nurs Outlook. 2011 Mar-Apr;59(2):95-106.e1. doi: 10.1016/j.outlook.2010.12.006.
Quaak M, Smerecnik C, van Schooten FJ, de Vries H, van Schayck CP Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers. BMJ Open. 2012 Jan 5;2:e000321. doi: 10.1136/bmjopen-2011-000321. Print 2012.
Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J. 2009 Mar;33(3):468-80. doi: 10.1183/09031936.00056908. Review.
Read CY, Perry DJ, Duffy ME Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale. J Nurs Scholarsh. 2005;37(3):203-8.
Sanderson SC, Michie S Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking. Clin Genet. 2007 Jun;71(6):501-10.
Sanderson SC, Waller J, Humphries SE, Wardle J Public awareness of genetic influence on chronic disease risk: are genetic and lifestyle causal beliefs compatible? Public Health Genomics. 2011;14(4-5):290-7. doi: 10.1159/000294280. Epub 2010 Apr 29.
Shadel WG, Mermelstein R, Borrelli B Self-concept changes over time in cognitive-behavioral treatment for smoking cessation. Addict Behav. 1996 Sep-Oct;21(5):659-63.
Smerecnik C, Grispen JE, Quaak M Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis. Tob Control. 2012 May;21(3):347-54. doi: 10.1136/tc.2011.042739. Epub 2011 Sep 26. Review.
Smerecnik CM, Mesters I, de Vries NK, de Vries H Applying a theory-based framework to understand public knowledge of genetic risk factors: a case for the distinction between how-to knowledge and principles knowledge. Public Health Genomics. 2011;14(4-5):259-70. doi: 10.1159/000294149. Epub 2010 Mar 12.
Smerecnik CM, Mesters I, de Vries NK, de Vries H Educating the general public about multifactorial genetic disease: applying a theory-based framework to understand current public knowledge. Genet Med. 2008 Apr;10(4):251-8. doi: 10.1097/GIM.0b013e31816b4ffd. Review.
Spielberger, C D. (1995a). Scoring information for the revised STPI. Tampa: Center for Research in Behavioral Medicine and Health Psychology, University of South Florida.
Spielberger, C D. (1995b). Preliminary Manual for the State-Trait Personality Inventory (STPI). Unpublished manual.
Weinman J, Petrie KJ Illness perceptions: a new paradigm for psychosomatics? J Psychosom Res. 1997 Feb;42(2):113-6.
Weinman, J , Petrie, K.J., Moss-Morris, R., & Horne, R. (1996). The illness perception questionnaire: A new method for assessing cognitive representations of illness. Psychology & Health, 11, 431-445.
Wright AJ, French DP, Weinman J, Marteau TM Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol. 2006 Nov;25(6):740-52.
Wright AJ, Weinman J, Marteau TM The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob Control. 2003 Jun;12(2):227-30.
Smokers' Response to Nicotine Dependence Genotyping
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.